Selective elimination of mitochondrial mutations in the germline by genome editing

Pradeep Reddy; Alejandro Ocampo; Keiichiro Suzuki; Jinping Luo; Sandra R. Bacman; Sion L. Williams; Atsushi Sugawara; Daiji Okamura; Yuji Tsunekawa; Jun Wu; David Lam; Xiong Xiong; Nuria Montserrat; Concepcion Rodriguez Esteban; Guang Hui Liu; Ignacio Sancho-Martinez; Dolors Manau; Salva Civico; Francesc Cardellach; Maria Del Mar O'Callaghan; Jaime Campistol; Huimin Zhao; Josep M. Campistol; Carlos T. Moraes; Juan Carlos Izpisua Belmonte

doi:10.1016/j.cell.2015.03.051

Selective elimination of mitochondrial mutations in the germline by genome editing

Pradeep Reddy, Alejandro Ocampo, Keiichiro Suzuki, Jinping Luo, Sandra R. Bacman, Sion L. Williams, Atsushi Sugawara, Daiji Okamura, Yuji Tsunekawa, Jun Wu, David Lam, Xiong Xiong, Nuria Montserrat, Concepcion Rodriguez Esteban, Guang Hui Liu, Ignacio Sancho-Martinez, Dolors Manau, Salva Civico, Francesc Cardellach, Maria Del Mar O'CallaghanJaime Campistol, Huimin Zhao, Josep M. Campistol, Carlos T. Moraes, Juan Carlos Izpisua Belmonte^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

215 Citations (SciVal)

Abstract

Mitochondrial diseases include a group of maternally inherited genetic disorders caused by mutations in mtDNA. In most of these patients, mutated mtDNA coexists with wild-type mtDNA, a situation known as mtDNA heteroplasmy. Here, we report on a strategy toward preventing germline transmission of mitochondrial diseases by inducing mtDNA heteroplasmy shift through the selective elimination of mutated mtDNA. As a proof of concept, we took advantage of NZB/BALB heteroplasmic mice, which contain two mtDNA haplotypes, BALB and NZB, and selectively prevented their germline transmission using either mitochondria-targeted restriction endonucleases or TALENs. In addition, we successfully reduced human mutated mtDNA levels responsible for Leber's hereditary optic neuropathy (LHOND), and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in mammalian oocytes using mitochondria-targeted TALEN (mito-TALENs). Our approaches represent a potential therapeutic avenue for preventing the transgenerational transmission of human mitochondrial diseases caused by mutations in mtDNA.

Original language	English (US)
Pages (from-to)	459-469
Number of pages	11
Journal	Cell
Volume	161
Issue number	3
DOIs	https://doi.org/10.1016/j.cell.2015.03.051
State	Published - Apr 23 2015
Externally published	Yes

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cell.2015.03.051

Cite this

Reddy, P., Ocampo, A., Suzuki, K., Luo, J., Bacman, S. R., Williams, S. L., Sugawara, A., Okamura, D., Tsunekawa, Y., Wu, J., Lam, D., Xiong, X., Montserrat, N., Esteban, C. R., Liu, G. H., Sancho-Martinez, I., Manau, D., Civico, S., Cardellach, F., ... Izpisua Belmonte, J. C. (2015). Selective elimination of mitochondrial mutations in the germline by genome editing. Cell, 161(3), 459-469. https://doi.org/10.1016/j.cell.2015.03.051

@article{783049e886eb4320a7adf95041beb709,

title = "Selective elimination of mitochondrial mutations in the germline by genome editing",

abstract = "Mitochondrial diseases include a group of maternally inherited genetic disorders caused by mutations in mtDNA. In most of these patients, mutated mtDNA coexists with wild-type mtDNA, a situation known as mtDNA heteroplasmy. Here, we report on a strategy toward preventing germline transmission of mitochondrial diseases by inducing mtDNA heteroplasmy shift through the selective elimination of mutated mtDNA. As a proof of concept, we took advantage of NZB/BALB heteroplasmic mice, which contain two mtDNA haplotypes, BALB and NZB, and selectively prevented their germline transmission using either mitochondria-targeted restriction endonucleases or TALENs. In addition, we successfully reduced human mutated mtDNA levels responsible for Leber's hereditary optic neuropathy (LHOND), and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in mammalian oocytes using mitochondria-targeted TALEN (mito-TALENs). Our approaches represent a potential therapeutic avenue for preventing the transgenerational transmission of human mitochondrial diseases caused by mutations in mtDNA.",

author = "Pradeep Reddy and Alejandro Ocampo and Keiichiro Suzuki and Jinping Luo and Bacman, {Sandra R.} and Williams, {Sion L.} and Atsushi Sugawara and Daiji Okamura and Yuji Tsunekawa and Jun Wu and David Lam and Xiong Xiong and Nuria Montserrat and Esteban, {Concepcion Rodriguez} and Liu, {Guang Hui} and Ignacio Sancho-Martinez and Dolors Manau and Salva Civico and Francesc Cardellach and {Del Mar O'Callaghan}, Maria and Jaime Campistol and Huimin Zhao and Campistol, {Josep M.} and Moraes, {Carlos T.} and {Izpisua Belmonte}, {Juan Carlos}",

note = "Funding Information: We thank M. Schwarz for administrative support. We thank S. Heinz and M.M. Ku from H.A. and Mary K. Chapman Charitable Foundations Genomic Sequencing Core at the Salk Institute for help with sequencing analysis. We thank M. Chang from the Integrative Genomics and Bioinformatics Core at the Salk Institute for sequencing data analysis. We thank C.B. Farrokhi from the Behavioral Testing Core at the Salk Institute for help with behavioral studies. We thank Eric Shoubridge from McGill University, Montreal, Canada for sharing with us the NZB/BALB/c heteroplasmic mice. We thank Julio Montoya Villarroya from the University of Zaragoza, Zaragoza, Spain, and M a {\'A}ngeles Ruiz G{\'o}mez from the Hospital de Son Espases, Palma de Mallorca, Spain. Financial support: M.M. Ku and S. Heinz are supported by the Leona M. and Harry B. Helmsley Charitable Trust. A.O. was partially supported by an NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship. G.-H.L. was supported by National Basic Research Program of China (973 Program, 2015CB964800; 2014CB964600), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), National Natural Science Foundation of China (NSFC: 81271266; 31222039; 31201111; 81371342). C.T.M. was supported by NIH grants 5R01EY010804, 1R01AG036871, the JDM Fund, the Muscular Dystrophy Association and the United Mitochondrial Disease Foundation. S.L.W. is supported by Florida Department of Health Grant 3KN09. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation and the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002). Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = apr,

day = "23",

doi = "10.1016/j.cell.2015.03.051",

language = "English (US)",

volume = "161",

pages = "459--469",

journal = "Cell",

issn = "0092-8674",

publisher = "Elsevier",

number = "3",

}

Reddy, P, Ocampo, A, Suzuki, K, Luo, J, Bacman, SR, Williams, SL, Sugawara, A, Okamura, D, Tsunekawa, Y, Wu, J, Lam, D, Xiong, X, Montserrat, N, Esteban, CR, Liu, GH, Sancho-Martinez, I, Manau, D, Civico, S, Cardellach, F, Del Mar O'Callaghan, M, Campistol, J, Zhao, H, Campistol, JM, Moraes, CT & Izpisua Belmonte, JC 2015, 'Selective elimination of mitochondrial mutations in the germline by genome editing', Cell, vol. 161, no. 3, pp. 459-469. https://doi.org/10.1016/j.cell.2015.03.051

TY - JOUR

T1 - Selective elimination of mitochondrial mutations in the germline by genome editing

AU - Reddy, Pradeep

AU - Ocampo, Alejandro

AU - Suzuki, Keiichiro

AU - Luo, Jinping

AU - Bacman, Sandra R.

AU - Williams, Sion L.

AU - Sugawara, Atsushi

AU - Okamura, Daiji

AU - Tsunekawa, Yuji

AU - Wu, Jun

AU - Lam, David

AU - Xiong, Xiong

AU - Montserrat, Nuria

AU - Esteban, Concepcion Rodriguez

AU - Liu, Guang Hui

AU - Sancho-Martinez, Ignacio

AU - Manau, Dolors

AU - Civico, Salva

AU - Cardellach, Francesc

AU - Del Mar O'Callaghan, Maria

AU - Campistol, Jaime

AU - Zhao, Huimin

AU - Campistol, Josep M.

AU - Moraes, Carlos T.

AU - Izpisua Belmonte, Juan Carlos

N1 - Funding Information: We thank M. Schwarz for administrative support. We thank S. Heinz and M.M. Ku from H.A. and Mary K. Chapman Charitable Foundations Genomic Sequencing Core at the Salk Institute for help with sequencing analysis. We thank M. Chang from the Integrative Genomics and Bioinformatics Core at the Salk Institute for sequencing data analysis. We thank C.B. Farrokhi from the Behavioral Testing Core at the Salk Institute for help with behavioral studies. We thank Eric Shoubridge from McGill University, Montreal, Canada for sharing with us the NZB/BALB/c heteroplasmic mice. We thank Julio Montoya Villarroya from the University of Zaragoza, Zaragoza, Spain, and M a Ángeles Ruiz Gómez from the Hospital de Son Espases, Palma de Mallorca, Spain. Financial support: M.M. Ku and S. Heinz are supported by the Leona M. and Harry B. Helmsley Charitable Trust. A.O. was partially supported by an NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship. G.-H.L. was supported by National Basic Research Program of China (973 Program, 2015CB964800; 2014CB964600), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), National Natural Science Foundation of China (NSFC: 81271266; 31222039; 31201111; 81371342). C.T.M. was supported by NIH grants 5R01EY010804, 1R01AG036871, the JDM Fund, the Muscular Dystrophy Association and the United Mitochondrial Disease Foundation. S.L.W. is supported by Florida Department of Health Grant 3KN09. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation and the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002). Publisher Copyright: © 2015 Elsevier Inc.

PY - 2015/4/23

Y1 - 2015/4/23

N2 - Mitochondrial diseases include a group of maternally inherited genetic disorders caused by mutations in mtDNA. In most of these patients, mutated mtDNA coexists with wild-type mtDNA, a situation known as mtDNA heteroplasmy. Here, we report on a strategy toward preventing germline transmission of mitochondrial diseases by inducing mtDNA heteroplasmy shift through the selective elimination of mutated mtDNA. As a proof of concept, we took advantage of NZB/BALB heteroplasmic mice, which contain two mtDNA haplotypes, BALB and NZB, and selectively prevented their germline transmission using either mitochondria-targeted restriction endonucleases or TALENs. In addition, we successfully reduced human mutated mtDNA levels responsible for Leber's hereditary optic neuropathy (LHOND), and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in mammalian oocytes using mitochondria-targeted TALEN (mito-TALENs). Our approaches represent a potential therapeutic avenue for preventing the transgenerational transmission of human mitochondrial diseases caused by mutations in mtDNA.

AB - Mitochondrial diseases include a group of maternally inherited genetic disorders caused by mutations in mtDNA. In most of these patients, mutated mtDNA coexists with wild-type mtDNA, a situation known as mtDNA heteroplasmy. Here, we report on a strategy toward preventing germline transmission of mitochondrial diseases by inducing mtDNA heteroplasmy shift through the selective elimination of mutated mtDNA. As a proof of concept, we took advantage of NZB/BALB heteroplasmic mice, which contain two mtDNA haplotypes, BALB and NZB, and selectively prevented their germline transmission using either mitochondria-targeted restriction endonucleases or TALENs. In addition, we successfully reduced human mutated mtDNA levels responsible for Leber's hereditary optic neuropathy (LHOND), and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in mammalian oocytes using mitochondria-targeted TALEN (mito-TALENs). Our approaches represent a potential therapeutic avenue for preventing the transgenerational transmission of human mitochondrial diseases caused by mutations in mtDNA.

UR - http://www.scopus.com/inward/record.url?scp=84928395483&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2015.03.051

DO - 10.1016/j.cell.2015.03.051

M3 - Article

C2 - 25910206

AN - SCOPUS:84928395483

SN - 0092-8674

VL - 161

SP - 459

EP - 469

JO - Cell

JF - Cell

IS - 3

ER -

Selective elimination of mitochondrial mutations in the germline by genome editing

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this